Abstract
Paracoccidioidomycosis is a dimorphic fungal infection endemic in Latin America. We report a patient with a history of pulmonary paracoccidioidomycosis who presented with relapsed disease in the central nervous system 4 years after initial treatment. We review current treatment strategies for paracoccidioidomycosis and neuroparacoccidioidomycosis.
Original language | English (US) |
---|---|
Article number | ofaa077 |
Journal | Open Forum Infectious Diseases |
Volume | 7 |
Issue number | 4 |
DOIs | |
State | Published - Mar 16 2020 |
Funding
Financial support. G. E. V. received funding from the National Institute of Allergy and Infectious Diseases (NIAID) at the US National Institutes of Health (NIH) (NIH/NIAID Grants K08 AI141740, L30 AI120170, and P30 AI060354), the Ronda Stryker and William Johnston Fellowship in Global Health and Social Medicine and the Dr. Lynne Reid/ Drs. Eleanor and Miles Shore Fellowship at Harvard Medical School, the Burke Global Health Fellowship at the Harvard Global Health Institute, and the Harvard University Center for AIDS Research. A. M. M. received funding from a postdoctoral research training award (NIH/NIAID Grant T32 AI007433).
Keywords
- Paracoccidioides brasiliensis
- central nervous system
- endemic mycosis
- neuroparacoccidioidomycosis
- paracoccidioidomycosis
ASJC Scopus subject areas
- Infectious Diseases
- Oncology